References
- Hanifin JM. Pharmacophysiology of atopic dermatitis. Clin Rev Allergy 1986;4:43–65
- Kuraishi Y, Nagasawa T, Hayashi K, Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 1995;275:229–233
- Sugimoto Y, Umakoshi K, Nojiri N, Kamei C. Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice. Eur J Pharmacol 1998;351:1–5
- Inagaki N, Nagao M, Igeta K, et al. Scratching behavior in various strains of mice. Skin Pharmacol Appl Skin Physiol 2001;14:87–96
- Matsuda H, Watanabe N, Geba GP, et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461–466
- Tohda C, Yamaguchi T, Kuraishi Y. Increased expression of mRNA for myocyte-specific enhancer binding factor (MEF) 2C in the cerebral cortex of the itching mouse. Neurosci Res 1997;29:209–215
- Matsushima Y. Japanese wild mice: a rich resource for new disease models. Exp Anim 2012;61:25–33
- Matsushima Y, Kikkawa Y, Takada T, et al. An atopic dermatitis-like skin disease with hyper-IgE-emia develops in mice carrying a spontaneous recessive point mutation in the Traf3ip2(Act1/CIKS) gene. J Immunol 2010;185:2340–2349
- Wu B, Jin M, Gong J, et al. Dynamic evolution of CIKS(TRAF3IP2/Act1) in metazoans. Dev Comp Immunol 2011;35:1186–1192
- Shinmei Y, Yano H, Kagawa Y, et al. Effect of Brazilian propolis on sneezing and nasal rubbing in experimental allergic rhinitis of mice. Immunopharmacol Immunotoxicol 2009;31:688–693
- Kanda Y. Investigation of the freely available easy-to-use software EZR for medical statistics. Bone Marrow Transplant 2013;48:452–458
- Sunada Y, Nakamura S, Kamei C. Effect of Lactobacillus acidophilus strain L-55 on the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol 2008;8:1761–1766
- Togashi Y, Umeuchi H, Okano K, et al. Antipruritic activity of the k -opioid receptor agonist, TRK-820. Eur J Pharmacol 2002;435:259–264
- Kim D-K, Kim H-J, Kim H, et al. Involvement of serotonin receptors 5-HT1 and 5-HT2 in 12(S)-HPETE-induced scratching in mice. Eur J Pharmacol 2008;579:390–394
- Weitzman G, Galli SJ, Dvorak AM, Hammel I. Cloned mouse mast cells and normal mouse peritoneal mast cells. Determination of serotonin content and ability to synthesize serotonin in vitro. Int Arch Allergy Appl Immunol 1985;77:189–191
- Takano N, Arai I, Hashimoto Y, Kurachi M. Evaluation of antipruritic effects of several agents on scratching behavior by NC/Nga mice. Eur J Pharmacol 2004;495:159–165
- Andoh T, Nagasawa T, Satoh M, Kuraishi Y. Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin recepotors in mice. J Pharmacol Exp Ther 1998;286:1140–1145
- Stander S, Siepmann D, Herrgott I, et al. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One 2010;5:1–5
- Ballantyne JC, Loach AB, Carr DB. Itching after epidural and spinal opiates. Pain 1988;33:149–160
- Metze D, Reimann S, Luger TA. Effective treatment of pruritus with naltrexone, an orally active opiate anatagonist. Ann NY Acd Sci 1999;885:430–432
- Bergasa NV, Alling DW, Talbot TL, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med 1995;123:161–167
- Monroe EW. Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic uticaria and atopic dermatitis. J Am Acad Dermatol 1989;21:135–136
- Yamamoto A, Kuyama S, Kamei C, Sugimoto Y. Characterization of scratching behavior induced by intradermal administration of morphine and fentanyl in mice. Eur J Pharmacol 2010;627:162–166
- Barke KE, Hough LB. Opiates, mast cell and histamine release. Life Sci 1993;53:1391–1399
- Blunk JA, Schmelz M, Zeck S, et al. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg 2004;98:364–370
- Narita I, Iguchi S, Omori K, Gejyo F. Uremic pruritus in chronic hemodialysis patients. J Nephrol 2008;21:161–165
- Nakao K, Mochizuki H. Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients. Drugs Today 2009;45:323–329